| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $80K | -22.3% | +60.0% |
| Cost of Revenue | $280K | -22.7% | -66.9% |
| R&D Expense | $1.2M | -16.8% | -65.7% |
| SG&A Expense | $1.2M | -23.4% | -61.5% |
| Operating Income | -$2.6M | +20.5% | +64.9% |
| Interest Expense | $1.5M | — | — |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.0M | -5.2% | -82.3% |
| Inventory | $2.5M | -0.2% | +21.6% |
| Current Assets | $4.9M | -0.5% | -65.3% |
| Total Assets | $5.6M | -1.8% | -63.1% |
| Current Liabilities | $6.9M | +91.0% | +63.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.0M | — | — |
| Capital Expenditures | $3K | — | — |
| Investing Cash Flow | -$3K | — | — |
| Financing Cash Flow | $3.1M | — | — |
| Free Cash Flow | -$9.0M | — | — |
| — |
| Net Income | -$4.0M | -24.9% | +44.0% |
| EPS (Basic) | -$4.73 | -1053.7% | -346.2% |
| EPS (Diluted) | -$4.73 | -1053.7% | -346.2% |
| $7.3M |
| +80.4% |
| +50.7% |
| Stockholders' Equity | -$1.7M | -203.9% | -116.6% |